CD91 Monoclonal / VioBright FITC / REA709

Product Details

Description	Clone REA709 recognizes the human CD91 antigen, also known as low density lipoprotein receptor-related protein 1 (LRP1), alpha-2-macroglobulin receptor (A2MR), or apolipoprotein E receptor (APOER). CD91 is a type 1 transmembrane protein receptor protein which is located in the plasma membrane of cells involved in receptor-mediated endocytosis. Furthermore, CD91 plays a role in lipoprotein metabolism and cell motility, and different diseases, such as neurodegenerative diseases, atherosclerosis, and cancer. CD91 is mainly expressed in liver, brain, and lung. \| Additional information: Clone REA709 displays negligible binding to Fc receptors.
Conjugate	VioBright FITC
Clone	REA709
Target Species	Human
Applications	FC
Supplier	Miltenyi Biotec
	Catalog #	Sign in to view product details, citations, and spectra
	Size
	Price
	Antigen
	Host
	Isotype

About CD91
This gene encodes a member of the low-density lipoprotein receptor family of proteins. The encoded preproprotein is proteolytically processed by furin to generate 515 kDa and 85 kDa subunits that form the mature receptor (PMID: 8546712). This receptor is involved in several cellular processes, including intracellular signaling, lipid homeostasis, and clearance of apoptotic cells. In addition, the encoded protein is necessary for the alpha 2-macroglobulin-mediated clearance of secreted amyloid precursor protein and beta-amyloid, the main component of amyloid plaques found in Alzheimer patients. Expression of this gene decreases with age and has been found to be lower than controls in brain tissue from Alzheimer's disease patients. [provided by RefSeq, Oct 2015]

About VioBright FITC
Vio®Bright FITC has an excitation peak at 496 nm and an emission peak at 522 nm. It is recommended for use in flow cytometry and fluorescence microscopy.

Experiment Design Tools